DOCSLIB.ORG

Walgreens: Financial Analysis and Recommendations

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Walgreens: Financial Analysis and Recommendations Fall 08 Walgreens: Financial Analysis and Recommendations By Madeleine Robinson A thesis submitted to the faculty of The University of Mississippi in partial fulfillment of the requirements of the Sally McDonnell Barksdale Honors College. Oxford May 2016 Approved by Advisor: Professor Victoria Dickinson © 2015 Madeleine Robinson ALL RIGHTS RESERVED ii ABSTRACT Madeleine Robinson: Walgreens: Financial Analysis and Recommendations (Under the direction of Victoria Dickinson) This thesis is an analysis including recommendations for the publically traded company, Walgreens. By using the most recent 10-K filing, a complete financial analysis was completed. Through the findings it was recommended to Walgreens that they focus more on mobile growth to compete with technology of competitors, as well as bring an in store area to represent their mobile presence. iii Table of Contents Introduction ................................................................................................................. 1 Chapter 1: General Company Information .................................................................... 2 The History of Walgreens ....................................................................................................................................... 2 The Beginnings ........................................................................................................................................................... 2 The Great Depression and Recovery ................................................................................................................ 3 World War II and Effects ........................................................................................................................................ 5 1950’s-1990’s .............................................................................................................................................................. 5 1990’s to the Present ............................................................................................................................................... 8 Walgreens’s Operations ....................................................................................................................................... 10 Core Business ........................................................................................................................................................... 10 Manufacturing Centers and Corporate Headquarters .......................................................................... 11 Value Chain ................................................................................................................................................................ 12 Board of Directors ................................................................................................................................................... 12 Chapter 2: Industry and Strategic Analyses ................................................................ 14 Walgreens’s Mission and Strategy ................................................................................................................... 14 Strategic Position in the Market and Competition .................................................................................... 16 Porter’s Five Forces ................................................................................................................................................ 18 Walgreens’s SWOT Analysis ............................................................................................................................... 19 Chapter 3: Financial Statement Analysis Part 1 ........................................................... 21 Asset Composition .................................................................................................................................................. 22 Walgreens’s Financing .......................................................................................................................................... 22 Cash Flows and Financial Health ...................................................................................................................... 22 Liquidity and Solvency .......................................................................................................................................... 23 Earnings Per Share ................................................................................................................................................. 24 Chapter 4: Financial Statement Analysis Part 2 ........................................................... 25 Receivables ................................................................................................................................................................ 25 Inventories ................................................................................................................................................................. 27 Property Plant and Equipment ......................................................................................................................... 30 Chapter 5: Financial Statement Analysis Part 3 ........................................................... 33 Walgreens’s Recent Investments ..................................................................................................................... 33 Restructuring Charges in Past Five Years ..................................................................................................... 35 Foreign Currency Changes ................................................................................................................................. 35 Stock Repurchases and Splits by Walgreens ............................................................................................... 36 Dividends ................................................................................................................................................................... 36 Pension Expense ..................................................................................................................................................... 37 iv Chapter 6: Financial Statement Analysis Part 4 ........................................................... 39 Operating Versus Non-Operating Items ........................................................................................................ 39 Effective Tax Rate .................................................................................................................................................... 41 Financial Analysis ................................................................................................................................................... 42 Limitations of Ratios .............................................................................................................................................. 49 Chapter 7: Accounting Quality .................................................................................... 50 Lagging Economic Indicators ............................................................................................................................ 50 Leading Economic Indicators ........................................................................................................................... 52 Effects of New Revenue Recognition Standard .......................................................................................... 53 Forecast Targets ..................................................................................................................................................... 53 Earnings Management ......................................................................................................................................... 53 Chapter 8: Equity Valuation ....................................................................................... 55 Capitalizing Leases ................................................................................................................................................ 55 Weighted Average Cost of Capital ................................................................................................................... 57 Forecast of Growth ................................................................................................................................................ 58 Stock Valuation ........................................................................................................................................................ 58 Chapter 9: Audit and Tax Recommendations .............................................................. 61 Management’s Assertions and Effects on Accounts ................................................................................ 63 Audit Risks and Internal Controls ................................................................................................................... 63 Tax Issues .................................................................................................................................................................. 64 Chapter 10: Audit and Tax Recommendations ............................................................ 67 Focus on Mobile Growth ..................................................................................................................................... 67 Corner of Healthy and Happy ..........................................................................................................................
Load more

Recommended publications
  • Walgreens Boots Alliance, Inc. 2017 Annual Report
    Annual Report 2017 Annual Report 2016 Board of Directors As of 24 October 2017 Back Row (from left to right) Middle Row (from left to right) Front Row (from left to right) José (Joe) E. Almeida Ginger L. Graham James A. Skinner Chairman of the Board and Former President and Chief Executive Executive Chairman, Walgreens Boots Chief Executive Officer, Baxter Officer, Amylin Pharmaceuticals Alliance, Inc. International Inc. David J. Brailer, MD Stefano Pessina William C. Foote Chairman, Health Evolution Partners Executive Vice Chairman and Chief Former Chairman and Chief Executive Executive Officer, Walgreens Boots Janice M. Babiak Officer, GUS Corporation Alliance, Inc. Former Managing Partner, Ernst & Dominic Murphy Young LLP Nancy M. Schlichting Founder and Chief Executive Officer, Former Chief Executive Officer, Henry 8C Capital LLP Ford Health System John A. Lederer Leonard D. Schaeffer Senior Advisor, Sycamore Partners Judge Robert Maclay Widney Chair and Professor, University of Southern California UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K È ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2017 ‘ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number 001-36759 WALGREENS BOOTS ALLIANCE, INC. (Exact name of registrant as specified in its charter) Delaware 47-1758322 (State of incorporation) (I.R.S. Employer Identification No.) 108 Wilmot
    [Show full text]
  • Prescription Savings for You and Your Family
    Prescription Savings for You and Your Family Filling a Prescription Shouldn’t ScriptSave® Works for Everyone! Empty Your Wallet Seniors with Medicare Part D With prescription drug costs on the rise, it can be diffi cult The ScriptSave® card can be used for prescriptions to fi t those expenses into your monthly budget. Even if you that are EXCLUDED by Medicare Part D law. do have insurance, some of your prescriptions may not be covered. That’s where ScriptSave® can help. Families with limited or no ScriptSave® has partnered with pharmacies all over the country prescription coverage to offer you and your family a program that saves you money If not everyone in your family has prescription and helps you maintain your health. With ScriptSave®, you have coverage or if your coverage does not cover all of access to both brand name and generic prescriptions. There are your prescriptions, the ScriptSave® card can help. no limits on usage and no income or age restrictions. Best of Use the ScriptSave® card for any brand name or all, you receive ScriptSave® savings at NO COST to you. generic prescription you or a family member pays for out-of-pocket. With the ScriptSave® Best Price Advantage, if a drug is ever “on sale,” or if the pharmacy price is less than the discounted Individuals with prescription coverage price, you will pay the lower of the two prices on your retail The ScriptSave® card can be used for prescriptions prescription purchases. that are not covered by your insurance or for savings for your family members not covered by Discover the savings with ScriptSave® yourself.
    [Show full text]
  • Pax High Yield Bond Fund USD 6/30/2021
    Pax High Yield Bond Fund USD 7/31/2021 Port. Ending Market Value Portfolio Weight Cco Holdings Llc 4.75% 01-mar-2030 7,647,097.94 1.2 Avantor Funding, Inc. 4.625% 15-jul-2028 6,545,260.64 1.0 Kraft Heinz Foods Co. 4.375% 01-jun-2046 6,005,601.47 0.9 Standard Industries, Inc. (new York) 5.0% 15-feb-2027 5,461,781.42 0.8 Nmg Holding Co., Inc. 7.125% 01-apr-2026 4,369,960.00 0.7 Univar Solutions Inc. 5.125% 01-dec-2027 4,360,224.83 0.7 Iqvia Inc. 5.0% 15-may-2027 4,348,808.89 0.7 Tenet Healthcare Corporation 5.125% 01-nov-2027 4,219,145.30 0.6 Ford Motor Company 9.0% 22-apr-2025 3,895,770.00 0.6 Seg Holding Llc 5.625% 15-oct-2028 3,874,948.10 0.6 Ncr Corporation 5.125% 15-apr-2029 3,837,059.24 0.6 Iron Mountain Incorporated 4.875% 15-sep-2029 3,815,423.04 0.6 Natura Cosmeticos S.a. 4.125% 03-may-2028 3,741,943.32 0.6 Mileage Plus Holdings Llc Term Loan 20-jun-2027 3,730,580.00 0.6 Cvr Partners, Lp 6.125% 15-jun-2028 3,695,204.98 0.6 Del Monte Foods, Inc. 11.875% 15-may-2025 3,599,114.57 0.6 Sprint Corp. 7.125% 15-jun-2024 3,595,709.53 0.6 Ally Financial Inc.
    [Show full text]
  • CVS Pharmacy Network
    Participating Retail Pharmacies The following list shows the major chain pharmacies and affiliated groups of independent community pharmacies that accept your prescription benefit ID card. In addition to these, most independent pharmacies nationwide also take part in your prescription program. To find out if a pharmacy not listed here accepts your card, call the pharmacy directly. A C (continued) G (continued) A & P Pharmacy CVS Caremark Specialty Pharmacy Giant Eagle Pharmacy AAP / United Drugs CVS/Longs Giant Pharmacy Accredo Health Group, Inc. CVS/pharmacy Good Neighbor Pharmacy ACME Pharmacy Albertson’s Pharmacy American Pharmacy Cooperative / D H American Pharmacy Network Solutions Dahl’s Pharmacy Haggen Pharmacy American Home Patient Dierbergs Pharmacy Hannaford Food & Drug American Pharmacy Dillon Pharmacy Happy Harry’s Ameridrug Pharmacy Discount Drug Mart Harmons Pharmacy Apria Healthcare, Inc. Doc’s Drugs Harps Pharmacy Doctor’s Choice Pharmacy Aurora Pharmacy Harris Teeter Pharmacy Dominick’s Pharmacy Harvard Drug Drug Town Pharmacy Harvard Vanguard Medical Association B Drug Warehouse Harveys Supermarket Pharmacy Baker’s Pharmacy Drug World H-E-B Pharmacy Bartell Drugs Drugs for Less Health Mart Basha’s United Drug Duane Reade HealthPartners Bel Air Pharmacy Duluth Clinic Hen House Pharmacy Bi-Lo Pharmacy Henry Ford Pharmacy Bi-Mart Pharmacy Hi-School Pharmacies Biggs Pharmacy E Hilander Pharmacy Bioscrip Pharmacy EPIC Homeland Pharmacy Bloom Pharmacy Eaton Apothecary Horton & Converse Brookshire Brothers Pharmacy Econofoods
    [Show full text]
  • USG Corporation 2016 Annual Report
    PART III Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE Executive Officers of the Registrant (as of February 8, 2017): Name Age Position Jennifer F. Scanlon 50 President and Chief Executive Officer Matthew F. Hilzinger 53 Executive Vice President and Chief Financial Officer Brian J. Cook 59 Executive Vice President and Chief Administrative Officer Dominic A. Dannessa 60 Executive Vice President, Chief Operations and Innovation Officer Chris A. Rosenthal 53 Senior Vice President, Human Resources Gregory D. Salah 54 Senior Vice President and President, North America Michelle M. Warner 50 Senior Vice President, General Counsel and Corporate Secretary Kenneth R. Banas 42 Vice President and Treasurer Mary A. Martin 61 Vice President and Associate General Counsel Jeanette A. Press 41 Vice President and Controller Srinivas Veeramasuneni 52 Vice President, Corporate Innovation Center Business Experience During the Last Five Years: Jennifer F. Scanlon has served as a Director since September 2016 and President and Chief Executive Officer since November 2016. Prior thereto Ms. Scanlon held a variety of positions at USG, including Executive Vice President beginning in March 2016 and President, International beginning in September 2010. Ms. Scanlon also served as President of L&W Supply Corporation from July 2015 to October 2016 and as the chairman of the board of USG Boral Building Products from its inception until October 2016. Matthew F. Hilzinger has served as Executive Vice President since April 2012 and Chief Financial Officer since May 2012. Prior to joining USG, he held various positions at Exelon Corporation, a utility services holding company engaged in the energy generation and delivery businesses, including serving as Executive Vice President and Chief Integration Officer in March 2012 and Senior Vice President and Chief Financial Officer prior thereto.
    [Show full text]
  • First Fill Temporary Pharmacy Card Making It Easy to Get Your Workers’ Compensation Prescriptions Filled
    First Fill Temporary Pharmacy Card Making it easy to get your workers’ compensation prescriptions filled. Employer: Print this page immediately upon receiving notice of injury, fill in the information below and give it to your employee. Injured Employee: 1. If you need a prescription filled for a work-related injury or illness, go to a Tmesys network pharmacy. 2. Give this page to the pharmacist. 3. The pharmacist will fill your prescription at no cost. Attention Pharmacists: Call 800.964.2531 to establish First Fill benefit eligibility and obtain the ID# for online adjudication Prescription Card of approved benefits for the injured worker. CARRIER/TPA EMPLOYER/OTHER ENTITY Tmesys is the designated PBM for this patient. Sedgwick CLIC INJURED WORKER NAME Tmesys Pharmacy SOCIAL SECURITY NUMBER DATE OF INJURY Help Desk 800.964.2531 Please provide directly to Pharmacist Notice to Cardholder: This card should be presented to your pharmacy to receive NDC Envoy medication for your work-related injury. It is only valid within 30 days of your date of injury. RxBin 004261 or 002538 For information regarding the program or to find nearby pharmacies call 866.599.5426. RxPCN CAL or Envoy Acct. # (To create a card for your wallet, cut along outer line and fold in half.) Pharmacist: 1. Call the Tmesys Pharmacy Help Desk at 800.964.2531. 2. Provide the information listed above. 3. The Help Desk will provide an ID number for adjudication. Finding a Network Pharmacy Use one of these easy methods to find a network pharmacy: ■ Visit one of the following pharmacy chains: Walgreens Walmart Duane Reade Publix Rite Aid CVS Kroger Safeway ■ Use our pharmacy locator online: www.pmsionline.com/pharmacy-center.
    [Show full text]
  • Sale Offering Memorandum
    WALGREEN'S 3063 S. SHERIDAN RD. TULSA, OK 74129 Barbara Kreis DRE#00797227 Senior Vice President 619.985.5592 [email protected] CalDRE #00797227 OFFERING MEMORANDUM PROPERTY INFORMATION 1 Property Summary Property Description Complete Highlights LOCATION INFORMATION 2 Regional Map Area Retail Location Maps Aerial Map DEMOGRAPHICS 3 Demographics Report Demographics Map ADVISOR BIOS 4 Advisor Bio & Contact 1 Back Page WALGREEN'S | 3063 S. SHERIDAN RD., TULSA, OK 74129 OFFERING MEMORANDUM 1 PROPERTY INFORMATION 3063 S. Sheridan Rd. Tulsa, OK 74129 WALGREEN'S | 3063 S. SHERIDAN RD., TULSA, OK 74129 | Page 3 Property Summary OFFERING SUMMARY PROPERTY OVERVIEW Sale Price: $3,115,000 An opportunity to own a Prime location Walgreens with a long term operating history and a NNN lease. This location was acquired by Walgreens in 2012 as part of the USA Drug Pharmacy Chain (May's Drugs) acquisition. Walgreens is a Cap Rate: 6.5% wholly owned subsidiary of Walgreens Boots Alliance Inc., a publicaly traded company (NASDAQ:WBA) with investment grade credit rated by Standard & Poor's. NOI: $202,500 The current 20 year lease expires in 2024 and provides 4, five year options offering rent increases in each option. Lot Size: 1.38 Acres At any time after Tenant has occupied the Premises f o r 20 years minimum, and upon written notice from Tenant, Landlord shall replace roof/HVAC units at its expense. Landlord's roofing or HVAC contractor may inspect to concur the Year Built: 2004 need f o r replacement was not caused by tenant neglect. Tenant is obligated to maintain service contracts on HVAC and r o o f with minimum twice annual service.
    [Show full text]
  • Fortune 500 Company List
    Fortune 500 Company List A • American International Group • Altria Group Inc • AmerisourceBergen Corporation • Albertson's, Inc. • Archer-Daniels-Midland Company • AT&T Corp • American Express Company • Alcoa • Abbott Laboratories • Aetna Inc. • AutoNation, Inc. • American Airlines - AMR • Amerada Hess Corporation • Anheuser-Busch Companies, Inc. • American Electric Power • Apple Computer, Inc • ALLTEL Corporation • AFLAC Incorporated • Arrow Electronics, Inc. • Amgen Inc • Avnet, Inc. • Aon Corporation • Aramark Corporation • American Standard Companies Inc. • ArvinMeritor Inc • Ashland • Applied Materials, Inc • Automated Data Processing • Avon Products, Inc. • Air Products and Chemicals Inc. • Assurant Inc • Agilent Technologies Inc • Amazon.com Inc. • American Family Insurance • Autoliv • Anadarko Petroleum Corporation • AutoZone, Inc. • Asbury Automotive Group, Inc. • Allied Waste Industries, Inc. • Avery Dennison Corporation • Apache Corporation • AGCO Corporation • AK Steel Holding Corp • Ameren Corporation • Advanced Micro Devices, Inc. • Auto-Owners Insurance • Avaya Inc. • Affiliated Computer Services, Inc • American Financial Group • Advance Auto Parts Inc B • Berkshire Hathaway • Bank of America Corporation • Best Buy Co., Inc. • BellSouth Corporation • Bristol-Myers Squibb Co. • Bear Stearns Companies • Burlington Northern Santa Fe Corporation • Baxter International Inc. • BJ's Wholesale Club, Inc. • Bank of New York Co. • BB&T Corporation • Baker Hughes • Barnes & Noble Inc • Boston Scientific Corp. • Burlington Resources.
    [Show full text]
  • USG Corporate Sustainability Report
    BUILDING IN HARMONY usg corporation sustainability update - december 2011 IN THIS ISSUE BUILDING IN HARMONY 3 A BLUEPRINT FOR ENVIRONMENTAL RESPONSIBILITY 5 EcoBlueprint™ Priority: Responsible Customer Solutions 7 Solutions Underway in 2010 8 SHEETROCK® Brand UltraLight Panels 8 New Packaging 8 More Functionality for LEED Reporting 8 Establishing Definitions for Product Content 8 Modeling Our Product Life Cycles 9 EcoBlueprint™ Priority: Enhance Energy Management 11 EcoBlueprint™ Priority: Improve How We Use Resources 13 SOCIAL RESPONSIBILITY 15 Even During Uncertain Times 15 Supporting Those in Need, Even Our Own 18 ECONOMIC RESPONSIBILITY 19 A Legacy of Leadership and Innovation 19 FOR MORE INFORMATION 21 2 BUILDING IN HARMONY USG CORPORATION SUSTAINABILITY UPDATE - DECEMBER 2011 BUILDING IN HARMONY Sustainability is about achieving balance. It is about creating architecture that coexists harmoniously with the world. For over a century, sustainable practices have naturally been an inherent part of our business at USG. Today, they help shape the innovative products that become the homes where we live, the buildings where we work and the arenas where we play. In 2010, USG published our first comprehensive Corporate Sustainability Report. An overview of our commitment to sustainable growth and responsible business practices, it outlined our efforts through 2009. This update highlights our recent efforts. 3 BUILDING IN HARMONY USG CORPORATION SUSTAINABILITY UPDATE - DECEMBER 2011 At USG, our approach to sustainability focuses on three dimensions of responsibility: environmental, social and economic. In this report, we will profile our efforts in these three areas. It should also be noted, despite the economic challenges endured by the construction industry and our company, our responsibilities continue to be a priority.
    [Show full text]
  • 2016 Sustainability Report About Usg
    USG CORPORATION 2016 SUSTAINABILITY REPORT ABOUT USG For 115 years, USG has been the leading manufacturer of building products and innovative solutions focused on helping our customers build the spaces where we live, work and play. We have expanded the boundaries of building science with products and systems that are safer, lighter, stronger and more sustainable. We put customers at the center of every decision we make, and our products enable architects, contractors and installers to not only build better structures, but to build a better world. While our innovative products shape building standards across the globe, we are also deeply committed to being a positive force in our local communities. Our 6,600 employees look to make a bigger impact in the places where we make and sell our products, and with the people who use them. WE ARE: A North American leader in producing gypsum wallboard, joint compound and a vast array of related products for the commercial, residential, and repair and remodel construction market. A leader in manufacturing ceiling suspension systems and an innovator in premier acoustical panel and specialty ceiling systems. Active around the world through joint ventures, subsidiaries and partners with manufacturing and distribution facilities in the Americas, Asia, Australia, Asia Pacific and the Middle East. PRESIDENT’S LETTER We are the leading manufacturer of building products and innovative building solutions that enable our customers to create sustainable, inspirational and inviting spaces. Our commitment to corporate citizenship extends beyond our manufacturing lines to our employees, our communities and the environment around us. Sustainability isn’t a trend at USG, it’s how we do business.
    [Show full text]
  • The People Shaping the Industry
    DRSN041208p81 4/21/08 3:46 PM Page 81 ANNUALANNUAL TheREPORT people shaping the industry --------------------------------2 Chains expand focus amid uncertain economy -------------15 The Drug Store News Power Rx 50---------------------------16 Mass retailers push pharmacy by expanding programs ---17 Regional players strengthen foothold by finding niche-----18 Supermarkets emphasize health/nutrition connection------19 Drug StoreStore News News www.drugstorenews.comwww.drugstorenews.com 08AprilApril 21, 21, 2008 2008• •81 1 DRSN_042108_p83.qxd 4/9/08 8:47 PM Page 83 08 ANNUALREPORT Bill Baxley, Kerr Drug ill Baxley, senior vice Baxley has been with Kerr for crease inventory.” The big- president of merchandis- more than 40 years, beginning gest long-term challenge? B ing and marketing for as a stock clerk in 1967. After “Constantly reinventing Kerr Kerr Drug, said if he weren’t in graduating from pharmacy Drugs,” he said. the drug store industry, he’d be school in 1971, he began work- Baxley said the most sur- of service to humanity, “devel- ing at Kerr’s Store No. 1 in prising development of the oping goals for peace.” Raleigh, N.C. past year occurred outside Those who know Baxley As a retailer, Baxley said with the “collapse of the finan- probably wouldn’t be surprised his top goal this year is to cial markets,” and of Bear by his altruistic leanings. “improve margin and de- Stearns in particular. Paul Beahm, Wal-Mart aul Beahm, senior vice the healthcare arena, where he’s tinue today, but after a major president and general spent the majority
    [Show full text]
  • April 20, 2021 Dear Stockholder: You Are Cordially Invited to Attend The
    April , 2021 Dear Stockholder: You are cordially invited to attend the Annual Meeting of Stockholders (the “Annual Meeting”) of Cornerstone Building Brands, Inc. (the “Company”) to be held at 10:00 a.m. EDT on Thursday, May 20, 2021. Due to concerns regarding the ongoing coronavirus (“COVID-19”) pandemic, and to protect the health and safety of our employees, stockholders and other stakeholders, the Annual Meeting will be a virtual meeting conducted solely online via live webcast at www.proxydocs.com/CNR. There is no physical location for the meeting. To participate in the Annual Meeting, you must register in advance at www.proxydocs.com/CNR prior to the registration deadline of 5:00 p.m. EDT on May 18, 2021. As part of the registration process, you must enter the control number provided in your proxy card. After completion of your registration, further instructions, including a unique link to access the Annual Meeting, will be emailed to you. At this meeting you will be asked to: (1) Proposal 1: Elect the four (4) Class I directors named in the accompanying proxy statement to serve until the 2024 Annual Meeting of Stockholders or until their respective successors have been elected and shall have qualified or until their resignation; (2) Proposal 2: Provide an advisory vote on executive compensation; (3) Proposal 3: Ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021; and (4) Transact such other business as may properly come before the Annual Meeting or any reconvened meeting following any adjournment or postponement thereof.
    [Show full text]